Femasys Inc. (FEMY) is a Healthcare stock trading at $2.70 (as of 2026-08-20), with a market capitalization of $163.05M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Understand Femasys Inc.: how it makes money
Femasys Inc. is a healthcare medical equipment company that generates revenue and currently operates at a loss, with results shown in its income statement.
The profit model shows a wide disconnect between gross margin 63% and operating margin -994%, meaning high gross profitability is not translating into operating earnings.
Business quality (Unprofitable): Unprofitable
Bull case
Gross margin indicates workable unit economics: Gross margin is 63%, which suggests the company retains meaningful value after direct costs. If operating expenses are brought under control, the company has room to improve operating results.
Bear case
Operating losses are extremely deep: Operating margin is -994%, indicating the company is far from covering operating expenses. This raises the risk that future performance depends on continued funding and rapid cost improvement.
Execution risk between gross and operating: With gross margin 63% but operating margin -994%, the gap implies operating cost pressure overwhelms the gross profit stream. That pattern can be difficult to fix quickly and may limit investor confidence in the path to profitability.
Valuation — source: SEC EDGAR (first-party)
Price
$2.70
Market Cap
$163.05M
Price / Book
22.37
Price / Sales
68.60
FCF Yield
-11.4%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)
$2.29M
Net Margin
-812.3%
Revenue Growth (YoY)
24.5%
EPS Growth (YoY)
-100.0%
FCF Growth (YoY)
-13.1%
Financial Health — source: SEC EDGAR
Altman Z-Score
-5.21 (distress)
Valuation vs Sector & Industry
Sector P/E (Healthcare)
21.6
Industry P/E (Medical Equipment)
32.9
Company
Sector
Healthcare
Industry
Medical Equipment
Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)